Go Pro

Broadway Financial (BYFC) Financials

Broadway Financial logo
$9.75 -0.25 (-2.50%)
Closing price 04:00 PM Eastern
Extended Trading
$9.69 -0.06 (-0.62%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Broadway Financial

Annual Income Statements for Broadway Financial

This table shows Broadway Financial's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
9.07 3.48 1.87 0.82 -0.21 -0.64 -4.05 5.64 4.33 0.36 -28
Consolidated Net Income / (Loss)
9.07 3.48 1.87 0.82 -0.21 -0.64 -3.95 5.71 4.35 1.95 -25
Net Income / (Loss) Continuing Operations
9.07 3.48 1.87 0.82 -0.21 -0.64 -3.95 5.71 4.35 1.95 -25
Total Pre-Tax Income
4.50 1.26 3.73 0.87 -0.55 -1.05 -4.89 8.12 6.26 2.77 -24
Total Revenue
14 12 14 11 12 13 24 34 35 33 35
Net Interest Income / (Expense)
11 11 12 10 10 12 21 33 29 32 33
Total Interest Income
15 15 16 15 17 18 25 36 49 64 61
Loans and Leases Interest Income
14 14 15 14 16 17 23 29 39 51 53
Investment Securities Interest Income
0.35 0.32 0.32 0.41 0.36 0.25 1.40 5.60 8.70 7.03 6.41
Other Interest Income
0.57 0.48 0.57 0.55 0.64 0.38 0.53 1.94 1.39 6.37 1.82
Total Interest Expense
3.86 3.88 4.35 4.93 6.39 5.48 3.75 3.41 19 32 28
Deposits Interest Expense
1.91 2.18 2.40 3.09 4.28 3.16 1.68 2.10 7.51 13 20
Long-Term Debt Interest Expense
1.95 1.70 1.95 1.84 2.11 2.31 2.07 1.31 12 19 8.21
Total Non-Interest Income
2.91 1.04 2.53 0.87 1.05 1.03 3.21 1.20 5.36 1.55 1.75
Service Charges on Deposit Accounts
- - - 0.45 - 0.42 0.25 0.15 0.18 0.16 0.18
Other Service Charges
0.80 0.78 0.11 0.11 0.62 0.13 0.92 1.05 1.02 1.12 1.29
Other Non-Interest Income
0.36 0.27 1.86 0.23 0.23 0.20 2.04 0.00 4.16 0.28 0.28
Provision for Credit Losses
-3.70 -0.55 -1.10 -1.25 -0.01 0.03 0.18 1.00 1.20 0.66 2.19
Total Non-Interest Expense
13 12 12 12 12 14 29 25 27 30 57
Salaries and Employee Benefits
8.11 7.03 7.09 7.06 7.36 8.36 16 14 16 18 19
Net Occupancy & Equipment Expense
2.39 2.24 2.40 2.39 2.43 2.58 5.88 4.72 4.65 4.62 5.05
Other Operating Expenses
2.48 2.29 2.15 1.92 2.10 3.27 6.65 5.34 6.67 7.38 7.12
Amortization Expense
- 0.19 0.20 0.20 0.18 0.00 0.39 0.44 0.39 0.34 0.32
Impairment Charge
- - - - - - - - - 0.00 26
Income Tax Expense
-4.57 -2.23 1.86 0.06 -0.35 -0.41 -0.94 2.41 1.91 0.82 0.34
Preferred Stock Dividends Declared
- - - - - - - - 0.00 1.57 3.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - 0.00 0.10 0.07 0.02 0.03 -0.01
Basic Earnings per Share
$0.31 $0.12 $0.07 $0.03 ($0.01) ($0.02) ($0.07) $0.62 $0.49 $0.04 ($3.23)
Weighted Average Basic Shares Outstanding
29.08M 27.42M 27.47M 27.89M 28.04M 27.90M 72.96M 73.51M - 9.12M 9.30M
Diluted Earnings per Share
$0.31 $0.12 $0.07 $0.03 ($0.01) ($0.02) ($0.07) $0.62 $0.49 $0.04 ($3.23)
Weighted Average Diluted Shares Outstanding
29.08M 27.42M 27.47M 27.89M 28.04M 27.90M 72.96M 73.51M - 9.12M 9.30M
Weighted Average Basic & Diluted Shares Outstanding
29.08M 27.42M 27.47M 27.89M 28.04M 27.90M 72.96M 73.51M - 9.12M 9.30M

Quarterly Income Statements for Broadway Financial

This table shows Broadway Financial's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
0.09 2.42 -0.15 0.19 -0.23 0.56 -3.44 0.00 -25 0.28 0.41
Consolidated Net Income / (Loss)
0.09 2.42 -0.17 0.26 0.54 1.33 -2.69 0.75 -24 1.03 1.15
Net Income / (Loss) Continuing Operations
0.09 2.42 -0.17 0.26 0.54 1.33 -2.69 0.75 -24 1.03 1.15
Total Pre-Tax Income
0.13 3.53 -0.23 0.40 0.74 1.86 -3.78 1.04 -23 1.42 1.43
Total Revenue
7.10 12 7.83 8.19 8.75 8.56 8.33 8.11 9.04 9.42 9.64
Net Interest Income / (Expense)
6.77 7.15 7.52 7.92 8.33 8.00 8.05 7.76 8.62 8.73 9.05
Total Interest Income
12 14 15 16 17 16 15 14 16 16 16
Loans and Leases Interest Income
9.41 12 12 13 13 13 13 13 13 14 13
Investment Securities Interest Income
2.18 2.15 2.08 1.88 1.64 1.45 1.21 1.17 1.69 2.34 2.61
Other Interest Income
0.34 0.36 1.59 1.43 1.74 1.61 0.48 0.40 0.68 0.26 0.31
Total Interest Expense
5.15 6.97 7.68 8.00 8.28 8.21 6.76 6.64 7.17 7.56 7.16
Deposits Interest Expense
2.13 2.53 2.80 3.09 3.21 4.09 4.20 4.88 5.36 5.49 5.99
Long-Term Debt Interest Expense
3.03 4.44 4.89 4.92 5.07 4.12 2.56 1.76 1.81 2.07 1.17
Total Non-Interest Income
0.33 4.48 0.31 0.27 0.42 0.56 0.29 0.36 0.42 0.69 0.59
Service Charges on Deposit Accounts
0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.04
Other Service Charges
0.29 0.28 0.27 0.24 0.38 0.24 0.21 0.21 0.23 0.63 0.18
Other Non-Interest Income
- - 0.00 0.00 0.00 0.28 0.04 0.11 0.15 - 0.36
Provision for Credit Losses
-0.00 0.34 0.25 0.51 0.41 -0.51 1.91 -0.45 0.68 0.05 0.20
Total Non-Interest Expense
6.98 7.76 7.81 7.28 7.59 7.21 10 7.52 32 7.95 8.02
Salaries and Employee Benefits
4.38 3.79 4.27 4.47 4.43 4.39 5.28 4.41 4.34 4.80 4.89
Net Occupancy & Equipment Expense
1.19 1.22 1.21 1.10 1.26 1.06 1.25 1.26 1.27 1.27 1.45
Marketing Expense
0.01 - 0.03 0.06 0.02 - 0.05 0.06 0.08 - 0.12
Other Operating Expenses
1.30 2.79 2.22 1.57 1.80 1.79 3.54 1.71 -0.11 1.98 1.48
Amortization Expense
0.10 0.10 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08
Income Tax Expense
0.04 1.10 -0.05 0.14 0.21 0.52 -1.09 0.30 0.74 0.39 0.28
Preferred Stock Dividends Declared
0.00 - 0.00 0.07 0.75 0.75 0.75 0.75 0.75 0.75 0.75
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.01 0.00 -0.02 0.00 0.02 0.02 -0.00 -0.01 -0.01 0.01 -0.01
Basic Earnings per Share
$0.01 - ($0.02) $0.02 ($0.03) $0.06 ($0.39) $0.00 ($2.86) $0.03 $0.05
Weighted Average Basic Shares Outstanding
- 0.00 9.13M 9.13M 9.11M 9.12M - - - 9.30M 9.28M
Diluted Earnings per Share
$0.01 - ($0.02) $0.02 ($0.03) $0.06 ($0.39) $0.00 ($2.86) $0.03 $0.05
Weighted Average Diluted Shares Outstanding
- 0.00 9.13M 9.13M 9.11M 9.12M - - - 9.30M 9.28M
Weighted Average Basic & Diluted Shares Outstanding
- 0.00 9.13M 9.13M 9.11M 9.12M - - - 9.30M 9.28M

Annual Cash Flow Statements for Broadway Financial

This table details how cash moves in and out of Broadway Financial's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
47 -49 3.79 -5.57 -1.09 81 135 -215 89 -44 -51
Net Cash From Operating Activities
14 0.93 -10 0.23 8.53 -14 0.62 6.32 7.59 1.39 0.23
Net Cash From Continuing Operating Activities
14 0.93 -10 0.23 8.53 -14 0.62 6.32 7.59 1.39 0.23
Net Income / (Loss) Continuing Operations
9.07 3.48 1.87 0.82 -0.21 -0.64 -3.95 5.71 4.35 1.95 -25
Consolidated Net Income / (Loss)
9.07 3.48 1.87 0.82 -0.21 -0.64 -3.95 5.71 4.35 1.95 -25
Provision For Loan Losses
-3.70 -0.55 -1.02 -1.21 -0.01 0.03 0.18 1.00 1.20 0.66 2.19
Depreciation Expense
0.24 0.25 0.26 0.24 0.23 0.12 0.29 0.38 0.39 0.42 0.41
Amortization Expense
0.54 0.55 0.54 0.84 0.46 0.42 0.83 0.44 -0.26 -0.26 0.46
Non-Cash Adjustments to Reconcile Net Income
4.58 -0.05 -111 -20 8.01 -13 0.85 -0.63 0.12 0.55 26
Changes in Operating Assets and Liabilities, net
3.44 -2.75 99 20 0.05 -0.23 2.43 -0.57 1.81 -1.93 -3.91
Net Cash From Investing Activities
-7.86 -74 30 -0.82 -39 51 25 -324 -131 28 -79
Net Cash From Continuing Investing Activities
-7.86 -74 30 -0.82 -39 51 25 -324 -131 28 -79
Purchase of Property, Leasehold Improvements and Equipment
-0.11 -0.16 -0.18 -0.08 -0.04 -0.42 -1.14 -0.32 -0.21 -0.14 -0.24
Purchase of Investment Securities
-116 -78 -32 -3.19 -44 48 -79 -345 -160 -103 -206
Sale and/or Maturity of Investments
108 3.60 62 2.44 4.88 2.76 21 22 29 131 126
Net Cash From Financing Activities
41 24 -16 -4.98 30 43 110 102 213 -74 28
Net Cash From Continuing Financing Activities
41 24 -16 -4.98 30 43 110 102 213 -74 28
Net Change in Deposits
55 15 3.86 -9.88 16 18 119 -101 -4.28 63 172
Issuance of Debt
21 20 30 33 22 60 5.00 96 488 342 956
Repayment of Debt
-35 -8.18 -50 -28 -8.77 -35 -36 -53 -375 -469 -1,111
Payment of Dividends
- - - - - 0.00 -0.06 -0.02 0.00 -1.57 -3.17
Other Financing Activities, Net
- - - -0.11 -0.01 0.00 -8.66 11 107 -6.87 14
Cash Interest Paid
3.88 3.77 4.20 4.90 6.34 5.77 3.72 3.05 17 31 28
Cash Income Taxes Paid
0.03 0.01 0.02 0.00 0.01 0.01 0.71 0.33 2.04 0.42 0.33

Quarterly Cash Flow Statements for Broadway Financial

This table details how cash moves in and out of Broadway Financial's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
0.75 94 -38 23 7.27 -36 -46 14 -9.78 -9.22 16
Net Cash From Operating Activities
1.89 3.57 -12 9.78 6.12 -2.84 -4.35 3.01 3.82 -2.26 1.13
Net Cash From Continuing Operating Activities
1.89 3.57 -12 9.78 6.12 -2.84 -4.35 3.01 3.82 -2.26 1.13
Net Income / (Loss) Continuing Operations
0.09 2.42 -0.17 0.26 0.54 1.33 -2.69 0.75 -24 1.03 1.15
Consolidated Net Income / (Loss)
0.09 2.42 -0.17 0.26 0.54 1.33 -2.69 0.75 -24 1.03 1.15
Provision For Loan Losses
-0.00 0.39 0.25 0.51 0.41 -0.51 1.91 -0.45 0.68 0.05 0.20
Depreciation Expense
0.17 -0.11 0.16 0.16 0.18 -0.08 0.10 0.10 0.10 0.10 0.11
Amortization Expense
0.54 -0.03 -0.04 -0.23 0.21 -0.21 0.03 0.09 0.07 0.27 0.04
Non-Cash Adjustments to Reconcile Net Income
0.00 -0.00 0.08 0.20 -0.18 0.44 0.31 0.15 26 -0.39 0.07
Changes in Operating Assets and Liabilities, net
1.09 0.89 -12 8.87 4.96 -3.82 -4.01 2.38 1.04 -3.31 -0.43
Net Cash From Investing Activities
-7.85 -70 -23 20 0.22 32 32 25 -123 -13 -68
Net Cash From Continuing Investing Activities
-7.85 -70 -23 20 0.22 32 32 25 -123 -13 -68
Purchase of Property, Leasehold Improvements and Equipment
-0.08 -0.09 -0.06 -0.05 -0.03 -0.01 -0.02 -0.01 -0.11 -0.11 -0.03
Purchase of Investment Securities
-74 -82 -0.14 - -88 -15 -2.68 -25 -134 -43 -95
Sale and/or Maturity of Investments
66 13 -23 20 88 46 35 51 11 30 26
Net Cash From Financing Activities
6.71 160 -3.27 -6.72 0.93 -64 -73 -14 109 6.47 83
Net Cash From Continuing Financing Activities
6.71 160 -3.27 -6.72 0.93 -64 -73 -14 109 6.47 83
Net Change in Deposits
25 11 13 -8.13 -15 73 31 22 50 68 155
Issuance of Debt
247 159 1.82 0.04 179 161 177 202 171 406 183
Repayment of Debt
-270 -106 -16 0.46 -179 -274 -294 -221 -123 -472 -255
Payment of Dividends
- - 0.00 -0.07 -0.75 -0.75 -0.75 -0.75 -0.75 -0.92 -0.75
Other Financing Activities, Net
3.83 98 -1.79 0.98 17 -23 14 -17 12 4.66 0.48
Cash Interest Paid
7.14 5.14 5.91 6.55 8.11 10 6.40 6.33 7.20 7.92 7.19

Annual Balance Sheets for Broadway Financial

This table presents Broadway Financial's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
403 429 414 409 440 483 1,094 1,184 1,407 1,335 1,346
Cash and Due from Banks
2.58 1.52 3.42 4.12 3.02 71 38 7.46 5.46 2.26 1.68
Interest Bearing Deposits at Other Banks
65 17 19 13 13 25 193 8.65 100 59 8.83
Trading Account Securities
14 13 17 15 11 11 156 329 317 204 257
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
2.57 2.48 2.41 2.24 2.78 2.54 10 10 9.19 8.90 8.73
Intangible Assets
- - - - 0.16 0.00 2.94 2.50 2.11 1.78 1.46
Other Assets
14 16 14 14 13 374 666 801 947 1,033 1,068
Total Liabilities & Shareholders' Equity
403 429 414 409 440 483 1,094 1,184 1,407 1,335 1,346
Total Liabilities
357 384 366 361 392 434 952 905 1,125 1,050 1,083
Non-Interest Bearing Deposits
273 287 291 281 298 316 788 687 683 745 918
Short-Term Debt
- - - - - 0.00 52 63 73 67 81
Long-Term Debt
77 90 70 75 88 114 100 142 255 227 72
Other Long-Term Liabilities
6.37 5.20 3.51 3.39 4.43 5.05 12 12 14 11 12
Total Equity & Noncontrolling Interests
46 46 47 48 49 49 141 280 282 285 263
Total Preferred & Common Equity
46 46 47 48 49 49 141 279 282 285 263
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 3.00 150 150 150 150
Total Common Equity
46 45 47 48 49 49 138 129 132 135 113
Common Stock
45 46 46 46 47 47 141 144 143 143 143
Retained Earnings
2.53 6.01 7.82 8.63 8.43 7.78 3.67 9.29 12 13 -15
Treasury Stock
-1.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33
Accumulated Other Comprehensive Income / (Loss)
-0.00 -0.10 -0.08 -0.28 -0.02 0.16 -0.55 -17 -14 -11 -6.11
Other Equity Adjustments
- -1.18 -1.10 -1.03 -0.96 -0.89 -0.83 -1.27 -4.49 -4.20 -3.87
Noncontrolling Interest
- - - - - 0.00 0.10 0.17 0.19 0.22 0.21

Quarterly Balance Sheets for Broadway Financial

This table presents Broadway Financial's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
1,238 1,370 1,367 1,373 1,259 1,248 1,336 1,426
Cash and Due from Banks
5.03 6.04 6.24 3.23 2.04 1.96 1.37 1.75
Interest Bearing Deposits at Other Banks
6.46 61 84 94 14 28 18 25
Trading Account Securities
316 293 261 238 186 178 244 284
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
9.92 9.73 9.61 9.47 8.81 8.72 8.73 8.66
Intangible Assets
2.21 2.03 1.94 1.86 1.70 1.62 1.54 1.38
Other Assets
872 972 979 1,000 1,021 1,004 1,062 1,105
Total Liabilities & Shareholders' Equity
1,238 1,370 1,367 1,373 1,259 1,248 1,336 1,426
Total Liabilities
963 1,089 1,085 1,086 975 963 1,074 1,163
Non-Interest Bearing Deposits
671 695 687 672 777 799 849 1,073
Short-Term Debt
76 72 73 90 81 64 76 81
Long-Term Debt
202 209 209 209 109 90 138 0.00
Other Long-Term Liabilities
14 13 16 16 8.42 9.63 11 9.09
Total Equity & Noncontrolling Interests
275 281 282 287 284 285 262 263
Total Preferred & Common Equity
275 281 282 286 284 285 262 262
Preferred Stock
150 150 150 150 150 150 150 150
Total Common Equity
125 131 132 136 134 135 112 112
Common Stock
145 143 143 142 143 143 143 144
Retained Earnings
9.95 12 13 13 9.29 9.29 -15 -15
Treasury Stock
-5.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33 -5.33
Accumulated Other Comprehensive Income / (Loss)
-19 -14 -13 -9.28 -9.51 -8.56 -6.94 -7.18
Other Equity Adjustments
-4.83 -4.42 -4.35 -4.28 -4.15 -4.09 -4.03 -3.81
Noncontrolling Interest
0.19 0.18 0.18 0.20 0.22 0.21 0.20 0.19

Annual Metrics And Ratios for Broadway Financial

This table displays calculated financial ratios and metrics derived from Broadway Financial's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
29,076,708.00 29,076,708.00 27,451,219.00 27,418,798.00 27,867,818.00 28,038,154.00 71,768,419.00 76,281,221.00 74,229,590.00 9,112,365.00 9,180,760.00
DEI Adjusted Shares Outstanding
3,634,589.00 3,634,589.00 3,431,402.00 3,427,350.00 3,483,477.00 3,504,769.00 8,971,052.00 9,535,153.00 9,278,699.00 9,112,365.00 9,180,760.00
DEI Earnings Per Adjusted Shares Outstanding
2.50 0.96 0.54 0.24 -0.06 -0.18 -0.44 0.60 0.47 0.21 -2.70
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.78% -12.27% 16.15% -22.78% 3.04% 14.60% 83.55% 40.62% 2.24% -4.30% 4.73%
EBITDA Growth
69.55% -61.08% 120.42% -56.93% -92.86% -467.63% -638.16% 336.85% -28.60% -54.07% -905.49%
EBIT Growth
77.65% -72.10% 197.37% -76.66% -163.26% -90.38% -365.78% 266.17% -22.92% -55.75% -983.71%
NOPAT Growth
258.72% -61.64% -46.29% -56.39% -147.33% -90.38% -365.78% 266.83% -23.75% -55.09% -976.61%
Net Income Growth
258.72% -61.64% -46.29% -56.39% -125.28% -211.65% -515.11% 244.49% -23.75% -55.09% -1,369.60%
EPS Growth
181.82% -61.29% -41.67% -57.14% -133.33% -100.00% -250.00% 244.49% -20.97% -91.84% -8,175.00%
Operating Cash Flow Growth
982.12% -93.43% -1,199.57% 102.29% 3,546.58% -258.85% 104.60% 913.46% 20.08% -81.66% -83.49%
Free Cash Flow Firm Growth
219.90% -162.70% 321.37% -124.87% -186.97% -87.07% -409.43% -39.64% 35.57% 127.76% 336.55%
Invested Capital Growth
-3.97% 10.03% -13.12% 4.84% 11.05% 18.60% 80.09% 65.68% 25.68% -5.15% -28.16%
Revenue Q/Q Growth
-3.39% -1.70% 0.91% -4.46% 3.09% 1.98% 16.29% 8.59% 7.05% -8.43% 2.53%
EBITDA Q/Q Growth
7.79% 257.49% 37.27% 157.33% 414.81% -429.68% -113.71% 114.45% 24.27% -38.43% 0.95%
EBIT Q/Q Growth
8.07% 678.34% 48.57% 764.89% 35.78% -104.48% -38.34% 114.05% 24.74% -37.62% -1.79%
NOPAT Q/Q Growth
117.97% 49.16% -46.01% 478.01% -81.85% -104.48% -38.34% 105.33% 26.04% -35.87% -1.79%
Net Income Q/Q Growth
118.81% -49.72% -58.18% 478.01% -249.28% -71.66% -36.93% 105.33% 26.04% -35.87% -1.22%
EPS Q/Q Growth
138.46% -50.00% -58.82% 200.00% 0.00% 0.00% -75.00% 105.33% 0.00% -83.33% 0.00%
Operating Cash Flow Q/Q Growth
258.85% -96.00% -24.66% 101.77% -59.14% 65.92% -97.93% 218.91% 51.31% -82.15% 164.79%
Free Cash Flow Firm Q/Q Growth
525.18% -400.10% 249.74% -215.25% -317.53% 34.93% 1.20% -117.72% 24.50% 214.33% 57.72%
Invested Capital Q/Q Growth
0.01% 10.61% -15.36% -8.57% 6.80% -3.41% -2.76% 24.52% 10.39% -1.07% -12.60%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
37.14% 16.47% 31.26% 17.43% 1.21% -3.87% -15.58% 26.23% 18.32% 8.79% -67.63%
EBIT Margin
31.68% 10.07% 25.79% 7.80% -4.79% -7.95% -20.18% 23.84% 17.97% 8.31% -70.12%
Profit (Net Income) Margin
63.89% 27.94% 12.92% 7.29% -1.79% -4.87% -16.31% 16.76% 12.50% 5.86% -71.09%
Tax Burden Percent
201.69% 277.29% 50.08% 93.57% 37.39% 61.20% 80.82% 70.28% 69.53% 70.57% 101.38%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
-101.69% -177.29% 49.92% 6.43% 0.00% 0.00% 0.00% 29.72% 30.47% 29.43% 0.00%
Return on Invested Capital (ROIC)
7.21% 2.69% 1.47% 0.68% -0.30% -0.49% -1.50% 1.47% 0.79% 0.33% -3.45%
ROIC Less NNEP Spread (ROIC-NNEP)
7.21% 2.69% 1.47% 0.68% -0.08% -0.40% -1.90% 1.47% 0.79% 0.33% -6.89%
Return on Net Nonoperating Assets (RNNOA)
14.54% 4.90% 2.55% 1.03% -0.13% -0.82% -2.66% 1.25% 0.76% 0.36% -5.61%
Return on Equity (ROE)
21.75% 7.59% 4.02% 1.71% -0.42% -1.31% -4.16% 2.71% 1.55% 0.69% -9.05%
Cash Return on Invested Capital (CROIC)
11.26% -6.86% 15.52% -4.05% -10.76% -17.51% -58.69% -47.98% -21.96% 5.62% 29.33%
Operating Return on Assets (OROA)
1.19% 0.30% 0.89% 0.21% -0.13% -0.23% -0.62% 0.71% 0.48% 0.20% -1.83%
Return on Assets (ROA)
2.41% 0.84% 0.44% 0.20% -0.05% -0.14% -0.50% 0.50% 0.34% 0.14% -1.85%
Return on Common Equity (ROCE)
21.75% 7.58% 4.02% 1.71% -0.42% -1.31% -4.09% 1.72% 0.72% 0.32% -4.09%
Return on Equity Simple (ROE_SIMPLE)
19.65% 7.64% 3.94% 1.69% -0.42% -1.31% -2.80% 2.04% 1.54% 0.69% -9.44%
Net Operating Profit after Tax (NOPAT)
9.07 3.48 1.87 0.82 -0.39 -0.73 -3.42 5.71 4.35 1.95 -17
NOPAT Margin
63.89% 27.94% 12.92% 7.29% -3.35% -5.57% -14.12% 16.76% 12.50% 5.86% -49.08%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% -0.22% -0.09% 0.40% 0.00% 0.00% 0.00% 3.44%
SG&A Expenses to Revenue
73.89% 74.40% 65.59% 84.53% 85.03% 82.92% 90.39% 56.27% 58.30% 66.57% 68.44%
Operating Expenses to Revenue
94.38% 94.34% 81.81% 103.43% 104.85% 107.73% 119.45% 73.23% 78.59% 89.71% 163.85%
Earnings before Interest and Taxes (EBIT)
4.50 1.26 3.73 0.87 -0.55 -1.05 -4.89 8.12 6.26 2.77 -24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5.27 2.05 4.52 1.95 0.14 -0.51 -3.77 8.93 6.38 2.93 -24
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.95 1.05 1.37 0.60 0.88 1.06 1.20 0.60 0.48 0.46 0.60
Price to Tangible Book Value (P/TBV)
0.95 1.05 1.37 0.60 0.88 1.06 1.52 0.76 0.61 0.58 0.61
Price to Revenue (P/Rev)
3.09 3.82 4.48 2.58 3.73 3.93 6.85 2.26 1.81 1.87 1.95
Price to Earnings (P/E)
4.84 13.66 34.66 35.32 0.00 0.00 0.00 13.67 14.55 172.43 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
20.66% 7.32% 2.88% 2.83% 0.00% 0.00% 0.00% 7.32% 6.87% 0.58% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.43 0.88 0.96 0.71 0.84 0.43 0.30 0.86 0.71 0.77 0.87
Enterprise Value to Revenue (EV/Rev)
3.74 9.57 7.79 7.81 10.05 5.27 3.69 12.24 12.53 13.35 10.33
Enterprise Value to EBITDA (EV/EBITDA)
10.08 58.09 24.91 44.78 832.27 0.00 0.00 46.67 68.38 151.80 0.00
Enterprise Value to EBIT (EV/EBIT)
11.82 94.99 30.19 100.16 0.00 0.00 0.00 51.35 69.70 160.63 0.00
Enterprise Value to NOPAT (EV/NOPAT)
5.86 34.26 60.28 107.04 0.00 0.00 0.00 73.07 100.25 227.62 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
3.75 128.18 0.00 372.82 13.56 0.00 143.07 65.93 57.44 319.29 1,567.00
Enterprise Value to Free Cash Flow (EV/FCFF)
3.75 0.00 5.73 0.00 0.00 0.00 0.00 0.00 0.00 13.31 2.47
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.67 1.98 1.48 1.56 1.81 2.33 1.08 0.74 1.16 1.03 0.58
Long-Term Debt to Equity
1.67 1.98 1.48 1.56 1.81 2.33 0.71 0.51 0.90 0.80 0.27
Financial Leverage
2.02 1.82 1.73 1.53 1.69 2.07 1.40 0.85 0.95 1.10 0.81
Leverage Ratio
9.04 9.07 9.07 8.61 8.76 9.45 8.30 5.41 4.61 4.83 4.89
Compound Leverage Factor
9.04 9.07 9.07 8.61 8.76 9.45 8.30 5.41 4.61 4.83 4.89
Debt to Total Capital
62.55% 66.43% 59.64% 60.94% 64.39% 69.95% 51.85% 42.40% 53.80% 50.72% 36.75%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.73% 13.07% 12.04% 11.51% 19.43%
Long-Term Debt to Total Capital
62.55% 66.43% 59.64% 60.94% 64.39% 69.95% 34.11% 29.32% 41.75% 39.21% 17.32%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.02% 30.90% 24.58% 25.92% 36.08%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.04% 0.03% 0.04% 0.05%
Common Equity to Total Capital
37.45% 33.50% 40.36% 39.06% 35.61% 30.05% 47.10% 26.67% 21.59% 23.32% 27.12%
Debt to EBITDA
14.62 43.91 15.50 38.55 635.50 -222.73 -40.27 23.04 51.45 100.17 -6.47
Net Debt to EBITDA
1.76 34.93 10.59 30.00 523.52 -34.65 21.11 21.23 34.96 79.23 -6.03
Long-Term Debt to EBITDA
14.62 43.91 15.50 38.55 635.50 -222.73 -26.50 15.93 39.94 77.44 -3.05
Debt to NOPAT
8.50 25.89 37.51 92.15 -229.03 -155.00 -44.42 36.07 75.44 150.20 -8.92
Net Debt to NOPAT
1.02 20.59 25.62 71.72 -188.67 -24.11 23.28 33.25 51.26 118.80 -8.31
Long-Term Debt to NOPAT
8.50 25.89 37.51 92.15 -229.03 -155.00 -29.22 24.95 58.55 116.11 -4.20
Noncontrolling Interest Sharing Ratio
0.00% 0.09% 0.09% 0.00% 0.00% 0.00% 1.63% 36.43% 53.49% 52.97% 54.81%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
14 -8.88 20 -4.89 -14 -26 -134 -187 -120 33 146
Operating Cash Flow to CapEx
12,761.26% 581.25% -5,587.98% 303.90% 20,812.20% -3,266.27% 54.83% 1,957.89% 3,650.96% 1,009.42% 94.65%
Free Cash Flow to Firm to Interest Expense
3.67 -2.29 4.52 -0.99 -2.20 -4.79 -35.67 -54.78 -6.20 1.04 5.18
Operating Cash Flow to Interest Expense
3.67 0.24 -2.35 0.05 1.34 -2.48 0.17 1.86 0.39 0.04 0.01
Operating Cash Flow Less CapEx to Interest Expense
3.64 0.20 -2.39 0.03 1.33 -2.55 -0.14 1.76 0.38 0.04 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.03
Fixed Asset Turnover
5.39 4.93 5.92 4.81 4.58 4.96 3.76 3.30 3.58 3.69 3.96
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
123 136 118 124 137 163 293 485 610 579 416
Invested Capital Turnover
0.11 0.10 0.11 0.09 0.09 0.09 0.11 0.09 0.06 0.06 0.07
Increase / (Decrease) in Invested Capital
-5.10 12 -18 5.71 14 26 130 192 125 -31 -163
Enterprise Value (EV)
53 119 113 87 116 70 89 417 436 445 360
Market Capitalization
44 48 65 29 43 52 166 77 63 62 68
Book Value per Share
$1.59 $1.56 $1.73 $1.76 $1.75 $1.74 $1.92 $1.70 $1.77 $14.81 $12.36
Tangible Book Value per Share
$1.59 $1.56 $1.73 $1.76 $1.75 $1.74 $1.52 $1.33 $1.40 $11.78 $12.20
Total Capital
123 136 118 123 137 163 293 485 610 579 416
Total Debt
77 90 70 75 88 114 152 206 328 293 153
Total Long-Term Debt
77 90 70 75 88 114 100 142 255 227 72
Net Debt
9.26 72 48 58 73 18 -80 190 223 232 142
Capital Expenditures (CapEx)
0.11 0.16 0.18 0.08 0.04 0.42 1.14 0.32 0.21 0.14 0.24
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 -0.18 -0.09 0.53 0.00 0.00 0.00 7.68
Net Nonoperating Obligations (NNO)
77 90 70 75 88 114 152 206 328 293 153
Total Depreciation and Amortization (D&A)
0.78 0.80 0.79 1.08 0.69 0.54 1.11 0.82 0.12 0.16 0.87
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.48 $0.96 $0.56 $0.24 ($0.08) ($0.16) ($0.56) $0.64 $0.52 $0.00 ($3.23)
Adjusted Weighted Average Basic Shares Outstanding
3.63M 3.43M 3.43M 3.49M 3.50M 3.49M 9.12M 9.19M 0.00 0.00 9.30M
Adjusted Diluted Earnings per Share
$2.48 $0.96 $0.56 $0.24 ($0.08) ($0.16) ($0.56) $0.64 $0.51 $0.00 ($3.23)
Adjusted Weighted Average Diluted Shares Outstanding
3.63M 3.43M 3.43M 3.49M 3.50M 3.49M 9.12M 9.19M 0.00 0.00 9.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 ($0.08) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
3.63M 3.43M 3.43M 3.49M 3.50M 3.49M 9.12M 9.19M 0.00 0.00 9.30M
Normalized Net Operating Profit after Tax (NOPAT)
3.15 0.88 1.87 0.82 -0.39 -0.73 -3.42 5.71 4.35 1.95 0.97
Normalized NOPAT Margin
22.17% 7.05% 12.92% 7.29% -3.35% -5.57% -14.12% 16.76% 12.50% 5.86% 2.78%
Pre Tax Income Margin
31.68% 10.07% 25.79% 7.80% -4.79% -7.95% -20.18% 23.84% 17.97% 8.31% -70.12%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.16 0.32 0.86 0.18 -0.09 -0.19 -1.30 2.38 0.32 0.09 -0.87
NOPAT to Interest Expense
2.35 0.90 0.43 0.17 -0.06 -0.13 -0.91 1.67 0.22 0.06 -0.61
EBIT Less CapEx to Interest Expense
1.14 0.28 0.82 0.16 -0.09 -0.27 -1.61 2.29 0.31 0.08 -0.88
NOPAT Less CapEx to Interest Expense
2.32 0.86 0.39 0.15 -0.07 -0.21 -1.22 1.58 0.21 0.06 -0.62
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.52% 0.26% 0.00% 80.19% -12.78%
Augmented Payout Ratio
0.00% 114.86% 0.00% 0.00% 0.00% 0.00% -1.52% 0.26% 40.93% 80.19% -12.78%

Quarterly Metrics And Ratios for Broadway Financial

This table displays calculated financial ratios and metrics derived from Broadway Financial's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
74,229,590.00 74,229,590.00 74,229,590.00 27,394,044.00 9,131,979.00 9,112,365.00 18,240,726.00 18,240,726.00 18,391,818.00 9,180,760.00 9,304,132.00
DEI Adjusted Shares Outstanding
9,278,699.00 9,278,699.00 9,278,699.00 27,394,044.00 9,131,979.00 9,112,365.00 18,240,726.00 18,240,726.00 18,391,818.00 9,180,760.00 9,304,132.00
DEI Earnings Per Adjusted Shares Outstanding
0.01 0.26 -0.02 0.01 0.06 0.15 -0.15 0.04 -1.30 0.11 0.12
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-20.83% 24.59% -8.56% 8.81% 23.11% -26.39% 6.42% -0.99% 3.35% 10.06% 15.71%
EBITDA Growth
-74.18% 57.98% -104.80% 294.12% 35.09% -53.87% -3,579.80% 268.66% -2,137.77% 14.50% 143.12%
EBIT Growth
-93.35% 54.33% -110.00% 17.11% 495.20% -47.38% -1,564.32% 162.47% -3,212.63% -23.23% 137.77%
NOPAT Growth
-93.61% 58.95% -109.96% 4.88% 525.58% -45.09% -1,564.32% 189.15% -3,113.12% -22.46% 143.30%
Net Income Growth
-93.61% 58.95% -110.85% 4.88% 525.58% -45.09% -1,456.07% 189.15% -4,541.26% -22.46% 142.53%
EPS Growth
-93.61% 0.00% -111.76% -33.33% -400.00% 0.00% -1,850.00% -100.00% -9,433.33% -50.00% 112.82%
Operating Cash Flow Growth
-66.80% 258.53% -406.87% 687.21% 223.94% -179.59% 62.72% -69.22% -37.48% 20.58% 125.92%
Free Cash Flow Firm Growth
-86.60% 35.97% 88.54% 105.19% 80.50% 126.82% 396.77% 1,298.45% 393.38% 400.25% 52.43%
Invested Capital Growth
41.76% 25.68% 5.40% -1.53% 5.84% -5.15% -15.76% -22.22% -18.68% -28.16% -27.41%
Revenue Q/Q Growth
-5.63% 63.63% -32.64% 4.61% 6.78% -2.17% -2.61% -2.68% 11.46% 4.18% 2.39%
EBITDA Q/Q Growth
882.35% 306.59% -102.92% 438.38% 236.72% 38.83% -332.63% 133.90% -1,961.21% 107.80% -12.38%
EBIT Q/Q Growth
-63.13% 2,720.00% -106.44% 274.89% 87.41% 149.33% -303.67% 127.58% -2,322.46% 106.15% 0.21%
NOPAT Q/Q Growth
-65.04% 2,718.60% -106.56% 262.37% 108.53% 147.40% -298.69% 128.21% -2,273.00% 106.37% 10.95%
Net Income Q/Q Growth
-65.04% 2,718.60% -107.14% 249.13% 108.53% 147.40% -302.25% 127.71% -3,302.95% 104.32% 10.95%
EPS Q/Q Growth
-65.04% 0.00% 0.00% 200.00% -250.00% 300.00% -750.00% 100.00% 0.00% 101.05% 66.67%
Operating Cash Flow Q/Q Growth
213.33% 89.14% -426.63% 183.87% -37.48% -146.47% -52.99% 169.25% 27.00% -159.02% 149.93%
Free Cash Flow Firm Q/Q Growth
6.43% 24.88% 76.30% 131.14% -451.69% 203.33% 162.24% 46.75% -26.22% 76.19% -20.09%
Invested Capital Q/Q Growth
-3.57% 10.39% -7.82% 0.35% 3.65% -1.07% -18.12% -7.36% 8.36% -12.60% -17.27%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
11.75% 29.21% -1.26% 4.09% 12.90% 18.30% -43.72% 15.23% -254.30% 19.04% 16.29%
EBIT Margin
1.76% 30.33% -2.90% 4.85% 8.51% 21.68% -45.34% 12.85% -256.20% 15.12% 14.80%
Profit (Net Income) Margin
1.21% 20.85% -2.21% 3.15% 6.15% 15.56% -32.31% 9.20% -264.34% 10.96% 11.88%
Tax Burden Percent
68.80% 68.77% 76.21% 64.99% 72.31% 71.75% 71.25% 71.59% 103.18% 72.47% 80.24%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
31.20% 31.23% 0.00% 35.01% 27.69% 28.25% 0.00% 28.41% 0.00% 27.53% 19.76%
Return on Invested Capital (ROIC)
0.08% 1.33% -0.13% 0.19% 0.39% 0.87% -2.07% 0.62% -11.51% 0.77% 1.05%
ROIC Less NNEP Spread (ROIC-NNEP)
0.08% 1.33% -0.13% 0.19% 0.39% 0.87% -2.09% 0.62% -14.51% 0.77% 1.05%
Return on Net Nonoperating Assets (RNNOA)
0.06% 1.26% -0.13% 0.20% 0.40% 0.96% -1.74% 0.48% -13.55% 0.63% 0.52%
Return on Equity (ROE)
0.14% 2.59% -0.25% 0.39% 0.80% 1.83% -3.82% 1.09% -25.06% 1.40% 1.57%
Cash Return on Invested Capital (CROIC)
-33.81% -21.96% -4.79% 2.00% -5.14% 5.62% 17.00% 24.98% 17.43% 29.33% 28.47%
Operating Return on Assets (OROA)
0.05% 0.82% -0.08% 0.13% 0.24% 0.53% -1.17% 0.33% -6.44% 0.39% 0.40%
Return on Assets (ROA)
0.03% 0.56% -0.06% 0.08% 0.17% 0.38% -0.83% 0.24% -6.64% 0.29% 0.32%
Return on Common Equity (ROCE)
0.07% 1.20% -0.12% 0.18% 0.37% 0.86% -1.79% 0.51% -11.34% 0.63% 0.71%
Return on Equity Simple (ROE_SIMPLE)
1.26% 0.00% 0.92% 0.92% 1.06% 0.00% -0.20% -0.03% -9.37% 0.00% -7.99%
Net Operating Profit after Tax (NOPAT)
0.09 2.42 -0.16 0.26 0.54 1.33 -2.64 0.75 -16 1.03 1.15
NOPAT Margin
1.21% 20.85% -2.03% 3.15% 6.15% 15.56% -31.74% 9.20% -179.34% 10.96% 11.88%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.02% 0.00% 3.00% 0.00% 0.00%
SG&A Expenses to Revenue
78.53% 43.06% 70.33% 68.70% 65.29% 63.69% 78.92% 70.68% 62.94% 64.48% 66.98%
Operating Expenses to Revenue
98.27% 66.72% 99.74% 88.88% 86.83% 84.27% 122.37% 92.75% 348.69% 84.38% 83.13%
Earnings before Interest and Taxes (EBIT)
0.13 3.53 -0.23 0.40 0.74 1.86 -3.78 1.04 -23 1.42 1.43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
0.84 3.40 -0.10 0.34 1.13 1.57 -3.64 1.24 -23 1.79 1.57
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.58 0.48 0.39 0.35 0.43 0.46 0.49 0.49 0.60 0.60 0.60
Price to Tangible Book Value (P/TBV)
0.75 0.61 0.49 0.45 0.54 0.58 0.62 0.62 0.61 0.61 0.61
Price to Revenue (P/Rev)
2.24 1.81 1.50 1.35 1.62 1.87 1.93 1.96 1.96 1.95 1.87
Price to Earnings (P/E)
21.31 14.55 19.66 18.43 26.48 172.43 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.69% 6.87% 5.09% 5.42% 3.78% 0.58% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.88 0.71 0.74 0.69 0.70 0.77 0.82 0.78 0.86 0.87 0.79
Enterprise Value to Revenue (EV/Rev)
15.03 12.53 12.18 11.20 11.27 13.35 11.53 10.10 12.08 10.33 7.52
Enterprise Value to EBITDA (EV/EBITDA)
95.26 68.38 98.47 87.15 86.21 151.80 0.00 1,191.93 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
97.46 69.70 110.35 101.88 92.43 160.63 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
141.65 100.25 160.72 149.98 134.66 227.62 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
97.43 57.44 0.00 108.78 52.56 319.29 44.76 175.99 0.00 1,567.00 47.74
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 34.27 0.00 13.31 4.43 2.72 4.45 2.47 2.34
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.01 1.16 1.00 1.00 1.04 1.03 0.67 0.54 0.82 0.58 0.31
Long-Term Debt to Equity
0.73 0.90 0.74 0.74 0.73 0.80 0.39 0.32 0.53 0.27 0.00
Financial Leverage
0.71 0.95 0.95 1.03 1.03 1.10 0.83 0.77 0.93 0.81 0.50
Leverage Ratio
4.36 4.61 4.59 4.64 4.65 4.83 4.65 4.61 4.94 4.89 4.91
Compound Leverage Factor
4.36 4.61 4.59 4.64 4.65 4.83 4.65 4.61 4.94 4.89 4.91
Debt to Total Capital
50.22% 53.80% 49.96% 49.95% 51.01% 50.72% 40.11% 35.10% 44.94% 36.75% 23.62%
Short-Term Debt to Total Capital
13.72% 12.04% 12.74% 12.87% 15.35% 11.51% 17.05% 14.53% 16.00% 19.43% 23.62%
Long-Term Debt to Total Capital
36.50% 41.75% 37.21% 37.08% 35.66% 39.21% 23.06% 20.57% 28.94% 17.32% 0.00%
Preferred Equity to Total Capital
27.14% 24.58% 26.67% 26.58% 25.64% 25.92% 31.66% 34.17% 31.53% 36.08% 43.61%
Noncontrolling Interests to Total Capital
0.03% 0.03% 0.03% 0.03% 0.03% 0.04% 0.05% 0.05% 0.04% 0.05% 0.06%
Common Equity to Total Capital
22.61% 21.59% 23.34% 23.44% 23.32% 23.32% 28.19% 30.68% 23.48% 27.12% 32.71%
Debt to EBITDA
54.07 51.45 66.64 63.12 62.70 100.17 -309.50 538.72 -8.97 -6.47 -4.42
Net Debt to EBITDA
51.83 34.96 50.72 43.01 42.30 79.23 -283.78 435.52 -8.14 -6.03 -2.97
Long-Term Debt to EBITDA
39.30 39.94 49.64 46.85 43.83 77.44 -177.94 315.69 -5.78 -3.05 0.00
Debt to NOPAT
80.40 75.44 108.77 108.63 97.92 150.20 -347.16 -1,606.60 -12.70 -8.92 -6.02
Net Debt to NOPAT
77.07 51.26 82.79 74.02 66.06 118.80 -318.30 -1,298.84 -11.53 -8.31 -4.05
Long-Term Debt to NOPAT
58.44 58.55 81.02 80.63 68.45 116.11 -199.59 -941.47 -8.18 -4.20 0.00
Noncontrolling Interest Sharing Ratio
54.34% 53.49% 53.51% 53.64% 53.47% 52.97% 53.14% 52.94% 54.77% 54.81% 54.97%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-163 -122 -29 9.02 -32 33 86 126 93 164 131
Operating Cash Flow to CapEx
2,302.44% 3,798.94% -21,207.27% 21,740.00% 21,089.66% -31,577.78% -28,986.67% 23,161.54% 3,607.55% -2,070.64% 3,415.15%
Free Cash Flow to Firm to Interest Expense
-31.57 -17.54 -3.77 1.13 -3.83 3.99 12.72 18.99 12.97 21.68 18.31
Operating Cash Flow to Interest Expense
0.37 0.51 -1.52 1.22 0.74 -0.35 -0.64 0.45 0.53 -0.30 0.16
Operating Cash Flow Less CapEx to Interest Expense
0.35 0.50 -1.53 1.22 0.74 -0.35 -0.65 0.45 0.52 -0.31 0.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.03 0.03 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.03 0.03
Fixed Asset Turnover
3.18 3.58 3.43 3.54 3.76 3.69 3.65 3.68 3.74 3.96 4.15
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
553 610 562 564 585 579 474 439 476 416 344
Invested Capital Turnover
0.07 0.06 0.06 0.06 0.06 0.06 0.07 0.07 0.06 0.07 0.09
Increase / (Decrease) in Invested Capital
163 125 29 -8.76 32 -31 -89 -125 -109 -163 -130
Enterprise Value (EV)
489 436 415 389 410 445 390 341 411 360 272
Market Capitalization
73 63 51 47 59 62 65 66 67 68 68
Book Value per Share
$1.68 $1.77 $1.77 $14.49 $14.94 $14.81 $14.66 $0.00 $12.15 $12.36 $12.25
Tangible Book Value per Share
$1.31 $1.40 $1.39 $11.44 $11.90 $11.78 $11.63 $0.00 $11.98 $12.20 $12.10
Total Capital
553 610 562 564 585 579 474 439 476 416 344
Total Debt
278 328 281 282 298 293 190 154 214 153 81
Total Long-Term Debt
202 255 209 209 209 227 109 90 138 72 0.00
Net Debt
266 223 214 192 201 232 174 125 194 142 55
Capital Expenditures (CapEx)
0.08 0.09 0.06 0.05 0.03 0.01 0.02 0.01 0.11 0.11 0.03
Net Nonoperating Expense (NNE)
0.00 0.00 0.01 0.00 0.00 0.00 0.05 0.00 7.68 0.00 0.00
Net Nonoperating Obligations (NNO)
278 328 281 282 298 293 190 154 214 153 81
Total Depreciation and Amortization (D&A)
0.71 -0.13 0.13 -0.06 0.38 -0.29 0.14 0.19 0.17 0.37 0.14
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.01 $0.00 ($0.02) $0.03 ($0.03) $0.06 $0.00 $0.00 ($2.86) $0.03 $0.05
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 9.13M 9.13M 9.11M 9.12M 0.00 0.00 0.00 9.30M 9.28M
Adjusted Diluted Earnings per Share
$0.01 $0.00 ($0.02) $0.03 ($0.03) $0.06 $0.00 $0.00 ($2.86) $0.03 $0.05
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 9.13M 9.13M 9.11M 9.12M 0.00 0.00 0.00 9.30M 9.28M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.06 $0.00 $0.00 $0.00 $0.03 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 9.13M 9.13M 9.11M 9.12M 0.00 0.00 0.00 9.30M 9.28M
Normalized Net Operating Profit after Tax (NOPAT)
0.09 2.42 -0.16 0.26 0.54 1.33 -2.64 0.75 1.89 1.03 1.15
Normalized NOPAT Margin
1.21% 20.85% -2.03% 3.15% 6.15% 15.56% -31.74% 9.20% 20.91% 10.96% 11.88%
Pre Tax Income Margin
1.76% 30.33% -2.90% 4.85% 8.51% 21.68% -45.34% 12.85% -256.20% 15.12% 14.80%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.02 0.51 -0.03 0.05 0.09 0.23 -0.56 0.16 -3.23 0.19 0.20
NOPAT to Interest Expense
0.02 0.35 -0.02 0.03 0.07 0.16 -0.39 0.11 -2.26 0.14 0.16
EBIT Less CapEx to Interest Expense
0.01 0.49 -0.04 0.04 0.09 0.22 -0.56 0.15 -3.24 0.17 0.19
NOPAT Less CapEx to Interest Expense
0.00 0.33 -0.03 0.03 0.06 0.16 -0.39 0.11 -2.27 0.12 0.16
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 2.58% 26.81% 80.19% -410.09% -3,896.10% -12.24% -12.78% -15.12%
Augmented Payout Ratio
0.00% 40.93% 0.00% 2.58% 26.81% 80.19% -410.09% -3,896.10% -12.24% -12.78% -15.12%

Financials Breakdown Chart

Key Financial Trends

Broadway Financial (NASDAQ: BYFC) showed a sharp turnaround in Q1 2026, posting stronger profitability and positive operating cash flow after a highly volatile 2025. The latest quarter suggests the company is still heavily dependent on deposit and funding management, but the core income statement improved meaningfully versus recent quarters.

  • Q1 2026 net income improved to $1.1 million, up from $1.0 million in Q4 2025 and well above the losses seen earlier in 2025.
  • Operating cash flow turned positive at $1.1 million in Q1 2026, a major improvement from negative operating cash flow in Q4 2025.
  • Revenue held up reasonably well at $9.6 million, with net interest income of $9.1 million doing most of the heavy lifting.
  • Net interest income improved sequentially from $8.7 million in Q4 2025 to $9.1 million in Q1 2026, helped by lower interest expense.
  • Common equity increased to $112.5 million from $111.7 million at year-end 2025, supporting the balance sheet.
  • Total assets rose to $1.43 billion from $1.34 billion in Q3 2025 and $1.24 billion in Q2 2025, reflecting a larger balance sheet.
  • Deposits were strong at $1.07 billion in non-interest-bearing deposits, which helps reduce funding costs, though it also highlights concentration in a single funding source.
  • The bank remains very reliant on investment securities, with trading account securities and other assets making up a large portion of the asset base and no meaningful loan balance shown in the data.
  • Non-interest expense remained elevated at $8.0 million, limiting pretax margin despite decent revenue.
  • Interest expense on cash/deposits and debt is still significant, with $7.2 million of interest expense in Q1 2026, which keeps pressure on profitability.

Looking at the broader trend, BYFC’s results have been extremely volatile over the last four quarters. Q3 2025 was especially weak, with a net loss of $23.9 million driven by a large impairment charge of $25.9 million. Since then, the company has recovered, with Q4 2025 and Q1 2026 both profitable again.

The balance sheet also shows a notable shift in structure. Compared with early 2024, total assets and liabilities have grown, but the company’s asset mix appears to have changed significantly, with a much larger reliance on securities and other assets while loans remain negligible in the reported data. That may support liquidity, but it can also make earnings more sensitive to interest rates and portfolio movement.

Bottom line: Broadway Financial appears to be stabilizing after a difficult stretch, and the latest quarter was encouraging on both earnings and cash flow. Still, the company remains highly vulnerable to earnings swings, funding costs, and balance-sheet mix changes, so investors should view the recovery as promising but not yet durable.

07/16/26 07:05 PM ETAI Generated. May Contain Errors.

Broadway Financial Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Broadway Financial's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Broadway Financial's net income appears to be on an upward trend, with a most recent value of -$24.81 million in 2025, falling from $9.07 million in 2015. The previous period was $1.95 million in 2024. See where experts think Broadway Financial is headed by visiting Broadway Financial's forecast page.

Over the last 10 years, Broadway Financial's total revenue changed from $14.20 million in 2015 to $34.90 million in 2025, a change of 145.8%.

Broadway Financial's total liabilities were at $1.08 billion at the end of 2025, a 3.1% increase from 2024, and a 203.5% increase since 2015.

In the past 10 years, Broadway Financial's cash and equivalents has ranged from $1.52 million in 2016 to $71.11 million in 2020, and is currently $1.68 million as of their latest financial filing in 2025.

Over the last 10 years, Broadway Financial's book value per share changed from 1.59 in 2015 to 12.36 in 2025, a change of 678.7%.



Financial statements for NASDAQ:BYFC last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners